Lexicon Pharmaceuticals LXRX
NASDAQ LXRX
$1.88 0.00 (-0.27%)
At close: Sep 30, 2026 · 4:00 PM EDT

Lexicon Pharmaceuticals (LXRX) Finished Goods (2023)

Updated

Lexicon Pharmaceuticals' Finished Goods was $172,000 in Q2 2023.

Analysis

Lexicon Pharmaceuticals (LXRX) Finished Goods (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Lexicon Pharmaceuticals 840.12 Mn 266.67 Mn 653,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 172,000.00
API Access

Lexicon Pharmaceuticals Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=LXRX&period=max&api_key=YOUR_API_KEY